title: [Osmotic activity of plasma in plasmapheresis in patients with multiple myeloma].
abstract: OBJECTIVE
  To control safety and efficiency of therapeutic plasmapheresis (PA) by osmolality, colloido-osmotic pressure (COP), total protein concentration before and after the procedure in patients with paraproteinemic hemoblastosis.
  
  
  METHODS
  20 patients with multiple myeloma have undergone 42 PA procedures conducted by two techniques: continuous flow centrifugation on blood fractioners or intermittent centrifugation of blood in plastic containers. The removed plasma volume averaged 1/3 (group 1) or 2/3 of the plasma volume (group 2). The removed protein reached 62-197 g. Isotonic sodium chloride solution and/or reopolyglucin (20-60 g) replaced the removed plasm. Total protein concentration was measured colorimetrically in biuretic reaction, plasma osmolality--cryoscopically and COP--on Knauer osmometer.
  
  
  RESULTS
  PA leads to a short decline in osmolality (97.0-99.1%), of total protein concentration (82.8-78.6%) and of COD (79.2% in replacement with saline and 90.2% in replacement with dextran). During recovery after the procedure plasma osmotic activity and protein concentration return to the baseline.
  
  
  CONCLUSIONS
  In elimination of 1/3 of plasma volume and crystalloid infusion, hemodilution promotes release of abnormal proteins from the tissues into the circulation and thereafter removal them from the organism. In removal of 1/2 and more of plasma volume, COP demans correction made by administration of colloids, e.g. solution of low molecular dextran. There is a potential danger of COD lowering several hours after PA due to different speed of dextran elimination and mobilization of protein reserve.
authors.forename: B E
authors.initials: BE
authors.lastname: Movshev
authors.forename: N N
authors.initials: NN
authors.lastname: Kalinin
authors.forename: M M
authors.initials: MM
authors.lastname: Petrov
authors.forename: V I
authors.initials: VI
authors.lastname: Petrova
authors.forename: V S
authors.initials: VS
authors.lastname: Zhuravlev
authors.forename: E S
authors.initials: ES
authors.lastname: Zakharova
authors.forename: N D
authors.initials: ND
authors.lastname: Khoroshko
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000628:therapy*; D009994:Osmolar Concentration; D009995:Osmosis; D010956:Plasmapheresis / Q000009:adverse effects / Q000379:methods; D012737:Sex Factors